{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:35Z","timestamp":1786988075587,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273789"],"award-info":[{"award-number":["82273789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ30778"],"award-info":[{"award-number":["2022JJ30778"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117266","type":"journal-article","created":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T10:05:41Z","timestamp":1736676341000},"page":"117266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A novel pyridine-2-one AMPK inhibitor: Discovery, mechanism, and in vivo evaluation in a hypoxic pulmonary arterial hypertension rat model"],"prefix":"10.1016","volume":"286","author":[{"given":"Wenhua","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117266_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2025.117266_bib2","first-page":"1590","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis in the era of new pulmonary arterial hypertension definitions","volume":"42","author":"Erdogan","year":"2024","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ejmech.2025.117266_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","article-title":"Epidemiology and treatment of pulmonary arterial hypertension","volume":"14","author":"Lau","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2025.117266_bib4","doi-asserted-by":"crossref","first-page":"15153","DOI":"10.1021\/acs.jmedchem.0c01093","article-title":"Targeted drugs for treatment of pulmonary arterial hypertension: past, present, and future perspectives","volume":"63","author":"Zheng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib5","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.1002\/anie.201302588","article-title":"The chemistry and biology of soluble guanylate cyclase stimulators and activators","volume":"52","author":"Follmann","year":"2013","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2025.117266_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.drudis.2022.01.011","article-title":"An emerging strategy for targeted therapy of pulmonary arterial hypertension: vasodilation plus vascular remodeling inhibition","volume":"27","author":"Hu","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.117266_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2213-2600(23)00264-3","article-title":"Treatment of pulmonary arterial hypertension: recent progress and a look to the future","volume":"11","author":"Humbert","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejmech.2025.117266_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/d41573-024-00054-y","article-title":"FDA approves Merck & Co's pulmonary arterial hypertension drug sotatercept","volume":"23","author":"Kingwell","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117266_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01347-2022","article-title":"Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2025.117266_bib10","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1021\/acs.jmedchem.4c01364","article-title":"Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial Hypertension","volume":"67","author":"Hu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib11","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1021\/acs.jmedchem.0c01132","article-title":"Discovery of novel pyrazolo[3,4-b] pyridine derivatives with dual activities of vascular remodeling inhibition and vasodilation for the treatment of pulmonary arterial hypertension","volume":"63","author":"Hu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116855","article-title":"Allosteric site identification, virtual screening and discovery of a sulfonamide Hsp 110-STAT3 interaction inhibitor for the treatment of hypoxic pulmonary arterial hypertension","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biochi.2021.11.008","article-title":"Role of AMPK mediated pathways in autophagy and aging","volume":"195","author":"Ge","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2025.117266_bib14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117266_bib15","doi-asserted-by":"crossref","first-page":"H1087","DOI":"10.1152\/ajpheart.00314.2020","article-title":"TIGAR reduces smooth muscle cell autophagy to prevent pulmonary hypertension","volume":"319","author":"Yamanaka","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejmech.2025.117266_bib16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMe2300324","article-title":"Continued progress in therapy for pulmonary arterial hypertension","volume":"388","author":"Taichman","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117266_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12931-015-0262-y","article-title":"Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells","volume":"16","author":"Price","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejmech.2025.117266_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70003","article-title":"Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension","volume":"28","author":"Yuan","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117266_bib19","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.7150\/ijbs.92992","article-title":"Metallothionein 3 potentiates pulmonary artery smooth muscle cell proliferation by promoting zinc-MTF1-ATG5 axis-mediated autophagosome formation","volume":"20","author":"Xiong","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2025.117266_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jjcc.2021.08.023","article-title":"Piperlongumine attenuates vascular remodeling in hypoxic pulmonary hypertension by regulating autophagy","volume":"79","author":"Ye","year":"2022","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ejmech.2025.117266_bib21","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1159\/000485886","article-title":"The protective effects of \u039a-opioid receptor stimulation in hypoxic pulmonary hypertension involve inhibition of autophagy through the AMPK-MTOR pathway","volume":"44","author":"Zhou","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2025.117266_bib22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40520-018-1063-1","article-title":"Autophagy and its role in pulmonary hypertension","volume":"31","author":"Chen","year":"2019","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.ejmech.2025.117266_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1165\/rcmb.2012-0446OC","article-title":"Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension","volume":"49","author":"Ibe","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117266_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2016.12.016","article-title":"Quercetin induces autophagy via FOXO1-dependent pathways and autophagy suppression enhances quercetin-induced apoptosis in PASMCs in hypoxia","volume":"103","author":"He","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.117266_bib25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.111.300483","article-title":"Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation","volume":"112","author":"Long","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.117266_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s13402-020-00584-8","article-title":"The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models","volume":"44","author":"Lemos","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ejmech.2025.117266_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202307695","article-title":"A novel AMPK inhibitor sensitizes pancreatic cancer cells to ferroptosis induction","volume":"11","author":"Schneider","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2025.117266_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chembiol.2015.05.011","article-title":"Inhibition of AMP-activated protein kinase at the allosteric drug-binding site promotes islet insulin release","volume":"22","author":"Scott","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117266_bib29","doi-asserted-by":"crossref","first-page":"8874","DOI":"10.1074\/jbc.RA118.003547","article-title":"AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965","volume":"293","author":"Dite","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112316","article-title":"Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors","volume":"197","author":"Matheson","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib31","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.celrep.2018.03.115","article-title":"Pro-inflammation associated with a gain-of-function mutation (R284S) in the innate immune sensor STING","volume":"23","author":"Konno","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.117266_bib32","doi-asserted-by":"crossref","first-page":"29060","DOI":"10.1074\/jbc.M503824200","article-title":"The Ca2+\/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases","volume":"280","author":"Hurley","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/cbt.10.1.12162","article-title":"SU11248 (sunitinib) directly inhibits the activity of mammalian 5'-AMP-activated protein kinase (AMPK)","volume":"10","author":"Laderoute","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejmech.2025.117266_bib34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1107\/S0907444911010201","article-title":"Structural basis for compound C inhibition of the human AMP-activated protein kinase \u03b12 subunit kinase domain","volume":"67","author":"Handa","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ejmech.2025.117266_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102247","article-title":"Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors","volume":"298","author":"Arter","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117266_bib37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117266_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/17460441.2017.1255194","article-title":"Targeting of AMP-activated protein kinase: prospects for computer-aided drug design","volume":"12","author":"Kim","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117266_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117266_bib40","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/tx200211v","article-title":"Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety","volume":"24","author":"Meanwell","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117266_bib41","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib42","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib43","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1021\/acs.jmedchem.9b01877","article-title":"Metabolic and pharmaceutical aspects of fluorinated compounds","volume":"63","author":"Johnson","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115476","article-title":"Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018-2022)","volume":"256","author":"Ali","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125466","article-title":"PF543-like compound, a promising sphingosine kinase 1 inhibitor: structure-based virtual screening and molecular dynamic simulation approaches","volume":"245","author":"Shahwan","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.117266_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116614","article-title":"Pseudolaric acid B suppresses NSCLC progression through the ROS\/AMPK\/mTOR\/autophagy signalling pathway","volume":"175","author":"Luo","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117266_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710001","article-title":"Molecular pathways in pulmonary arterial hypertension","volume":"23","author":"Shah","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117266_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175725","article-title":"Endothelial progenitor cell-derived exosomes inhibit pulmonary artery smooth muscle cell in vitro proliferation and resistance to apoptosis by modulating the Mitofusin-2 and Ras-Raf-ERK1\/2 signaling pathway","volume":"949","author":"Liu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117266_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ame2.12220","article-title":"Experimental animal models of pulmonary hypertension: development and challenges","volume":"5","author":"Wu","year":"2022","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.ejmech.2025.117266_bib50","doi-asserted-by":"crossref","first-page":"C555","DOI":"10.1152\/ajpcell.00289.2019","article-title":"Structural and functional definition of the pulmonary vein system in a chronic hypoxia-induced pulmonary hypertension rat model","volume":"318","author":"Wu","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejmech.2025.117266_bib51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/rccm.202302-0327SO","article-title":"Pulmonary hypertension: a contemporary review","volume":"208","author":"Johnson","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2025.117266_bib52","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood.2022016934","article-title":"NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts","volume":"141","author":"Zhang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.117266_bib53","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acs.jmedchem.2c01601","article-title":"METTL3 from target validation to the first small-molecule inhibitors: a medicinal chemistry journey","volume":"66","author":"Fiorentino","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117266_bib54","article-title":"Novel pyrazolo[3,4-b] pyridine derivative (HLQ2g) attenuates hypoxic pulmonary hypertension via restoring cGKI expression and BMP signaling pathway","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117266_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107017","article-title":"TPN171H alleviates pulmonary hypertension via inhibiting inflammation in hypoxia and monocrotaline-induced rats","volume":"145","author":"Zhao","year":"2022","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117266_bib56","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.7150\/ijbs.48933","article-title":"MicroRNA-216b targets HK2 to potentiate autophagy and apoptosis of breast cancer cells via the mTOR signaling pathway","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2025.117266_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116505","article-title":"Canagliflozin inhibits PASMCs proliferation via regulating SGLT1\/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension","volume":"174","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T21:38:39Z","timestamp":1740346719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":57,"alternative-id":["S0223523425000315"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117266","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel pyridine-2-one AMPK inhibitor: Discovery, mechanism, and in vivo evaluation in a hypoxic pulmonary arterial hypertension rat model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117266"}}